BioSpace News Archive

Cytonus Therapeutics Inc. announced that it will be presenting preclinical data for its Cargocyte™ technology platform at the American Association for Cancer Research annual meeting March 29 – April 3, at the Georgia World Congress Center in Atlanta.

The Society for Functional Precision Medicine (SfPM), in collaboration with Labcyte and SpeciCare, is proud to announce it will be hosting the first annual Functional Precision Medicine Summit in Atlanta on March 30, 2019.

Torus Tech, a specialized research and development company, published a new research paper, “Resolving the Vacuum Catastrophe: A Generalized Holographic Approach,” in the Journal of High Energy Physics, Gravitation and Cosmology.

A replay of the webcast will be available for 90 days following the conclusion of the live presentation broadcast.

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced it has been recognized by Frost & Sullivan for best practices in Technology Innovation in the Rapid Diagnostics Industry.

Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, adds Michael Levitt, Ph.D., of Stanford University , to its roster of high-profile advisors.

Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announced a new local production initiative to bring the benefits of the T-SPOT®.TB test to the Russian Federation.

Queen’s University Belfast and Domainex are pleased to announce that their joint project team has successfully identified novel first-in-class small molecule inhibitors of the anti-apoptotic protein FLIP.

Since 2015, hard-working Canadians have proven what has long been understood: a strong economy starts with a strong middle class.

Total Revenue in Q4 was $22.9 Million